Lauren S. Schlesselman, PharmD
CASE ONE:While working at Sunny Day
Pharmacy, the pharmacist is
approached by a woman and
her teenage daughter. The
woman asks the pharmacist if
she would mind looking at her
daughter's sunburn.
The pharmacist notices that
the daughter has visible first-degree
sunburn on her face
and exposed extremities. Her arms and legs have some second-
degree blisters that show early signs of healing.
When the pharmacist questions her about the sunburn, the
teenager explains that she developed the sunburn while on
vacation at the beach. When questioned about her use of sunscreen,
she insists that she applied sunscreen with a sun protection
factor of 30 each day and would reapply it frequently
throughout the day. The teenager claims that she usually develops
a suntan easily, rarely burning.
The mother asks if the pharmacist has any recommendations
for an OTC medication to alleviate the sunburn. The pharmacist
recommends ibuprofen to decrease the pain. When the
pharmacist takes the teenager to the analgesic aisle, he asks
her if she is taking any prescription or OTC medications. She
says she is just finishing a course of antibiotics. Although she
cannot remember the name of the medication, she does
remember that the name "looks like 2 names," and it is a "huge
white pill."
Considering the severity of the teenager's sunburn, what
antibiotic does the pharmacist suspect she is taking?
CASE TWO:Before morning rounds, the
medical resident notes that the
phenytoin level for one of the
patients is now in the chart.
When he sees that the level was
only 5.8, he wants to impress
his attending physician by not
only knowing that the level is
below the therapeutic range, but also by having a plan for
increasing the dose. He asks the pharmacy student to calculate
a dosage adjustment, informing the student that he would like to
have the recommendation ready when rounds begin.
The pharmacy student begins reviewing the medical chart for
the patient. He notices that the patient has not had any seizures
while taking phenytoin 200 mg orally 3 times a day. This morning's
laboratory results also show that the patient's serum albumin
was reported as 2.0 g/dL, while his serum creatinine was
reported as 0.9 mg/dL.
When morning rounds begin, the medical resident asks the
pharmacy student to inform the attending physician what
dosage adjustment should be made. The pharmacy student
shocks the resident by recommending that the dose be maintained
at 200 mg 3 times daily. The pharmacist working with the
student agrees with the recommendation.
Why did the pharmacy student not recommend a dosage
increase?
Dr. Schlesselman is an assistant clinical professor at the University of Connecticut School of Pharmacy.
| Click Here For The Answer -----------> |
[-] |
CASE ONE: The pharmacist suspects the teenager is taking sulfamethoxazole-trimethoprim. Photosensitivity reactions are known to
occur with this medication. The primary treatment is discontinuance of the antibiotic. The reaction will persist 1 to 2 days after
discontinuation.
CASE TWO: The pharmacy student made the recommendation because he knew that phenytoin is highly protein-bound. Phenytoin serum assays
measure total phenytoin, bound and unbound. Alterations in protein binding must be accounted for when evaluating levels. The student was able
to
account for binding alteration due to hypoalbuminemia using the following equation: adjusted concentration = measured concentration/([0.2 x
albumin] +0.1). The pharmacy student also realizes that it is important to treat the patient, rather than the level. Regardless of the
levels, the patient has not experienced
any seizures. Increasing the dose would only increase the risk of adverse effects.